Arcturus Therapeutics Statistics
NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.77-0.235 (-1.81%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Arcturus Therapeutics by the numbers
Arcturus Therapeutics has a market capitalization of $362.8 million based on 28.42M shares outstanding. With trailing EPS of $-3.33, Arcturus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.4% above its 50-day average and 49.0% above its 200-day average.
Average daily trading volume is 938.70K shares, or about $12.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARCT valuation vs. peer median
| Metric | ARCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $362.82M | $363.79M | -0% |
| Avg. volume | 938.70K | 772.14K | +22% |
Peer median across 8 companies: TTRX, IRD, GALT, EBS, ENTA, RLMD, AVIR, CYPH.
Valuation
- Market cap
- $362.82M
- EPS (TTM)
- $-3.33
- Shares outstanding
- 28.42M
Price and trading
- Previous close
- 13.00
- Open
- 12.71
- Day range
- 12.59 – 13.40
- 52-week range
- 5.50 – 24.17
- 52-week change
- -37.64%
- Beta
- —
- Volume
- 517.07K
- Average volume
- 938.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 362.82M
- Forward Pe
- -3.52
- Eps
- -3.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.17
- Week52 Low
- 5.50
- Avg Volume
- 938.70K
- Shares Outstanding
- 28.42M
- Ma50
- 12.11
- Ma200
- 8.57
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -47.19%
- Pct From52w Low
- 132.09%